ENTRY       D10571            Mixture   Drug
NAME        Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine;
            Complera (TN);
            Eviplera (TN)
PRODUCT     COMPLERA (Gilead Sciences)
COMPONENT   Rilpivirine hydrochloride [DR:D09958], Tenofovir disoproxil fumarate [DR:D01982], Emtricitabine [DR:D01199]
CLASS       Antiviral
             DG03107  Anti-HIV agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      ATC code: J05AR08
            Product: D10571<US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Rilpivirine is primarily metabolized by CYP3A.
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine
                  D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Emtricitabine/ Rilpivirine/ Tenofovir Disoproxil Fumarate
                D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D10571  Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10571
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10571
DBLINKS     PubChem: 254741533
///
